NCT/Study#

HDAC/OX40

Phase I/II clinical trial of combination of OX40 and HDAC inhibitor in patients with Stage IV NSCLC

Phase I/II clinical trial of combination of OX40 and HDAC inhibitor in patients with Stage IV NSCLC

DISEASE GROUP:
Phase 1
current phase:
Phase I/II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: